Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on UV P. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109574961B details a high-yield synthesis for Sofosbuvir intermediates. Discover cost-effective manufacturing solutions and supply chain advantages.
Patent CN104761582A details a mild route for Sofosbuvir intermediates ensuring high purity and scalable manufacturing for global supply chain reliability.
Patent CN102603509B reveals a 3-step synthesis for high-purity photoinitiators, offering significant cost reduction and supply chain reliability for UV curing applications.
Advanced UV curing additive with red-shifted absorption. Scalable synthesis route for high-purity photoinitiators used in coatings and electronics.
Advanced nitrile-based route for 2-isopropyl thioxanthone offers high purity and yield. Ideal for UV curing applications. Cost-effective manufacturing solution.
Novel 7-step synthesis for rosuvastatin calcium intermediates. High yield, mild conditions, cost-effective manufacturing for global supply chains.
Novel 7-step route for Rosuvastatin calcium intermediate using vinyl chloride. Cost-effective, scalable, high purity manufacturing solution.
Patent CN110981863A details a novel route for Sofosbuvir intermediates using unique imidate donors, offering superior beta-selectivity and streamlined purification for API manufacturing.
Patent CN102040561A reveals a green synthesis method for benzotriazole UV absorbers using acidic ionic liquids, offering high yields and reduced environmental impact for polymer additive manufacturing.
Patent CN111635301B details a condensation method for photoinitiators matching 365nm+ LED sources, offering superior conversion rates and scalable production for industrial coatings.
Patent CN118324765A reveals a novel Ir-catalyzed route for Duvelisib, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN109456300B reveals a novel oxidation method reducing impurities below 0.05%, ensuring reliable supply and cost reduction in API manufacturing.
Advanced patent CN106478518A enables high-purity Rosuvastatin intermediate production with improved safety and scalability for global supply chains.
Patent CN105859761A reveals UV-induced metal-free synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chains.
Patent CN111471034A details a continuous flow oxidation method for rosuvastatin intermediate D7, offering high purity, safety, and scalable manufacturing solutions.
Patent CN109369406A enables photocatalytic synthesis of high-purity photoinitiators. Achieve cost reduction in UV photocuring manufacturing with scalable green chemistry.
Patent CN113754650A reveals a novel route for rosuvastatin calcium intermediates, drastically reducing cis-isomer impurities and enhancing pharmaceutical manufacturing efficiency.
Novel patent CN104844525A offers high-yield route for Rosuvastatin impurity. Enhances quality control and supply chain stability for global pharmaceutical manufacturers.
Advanced synthesis of 1-(biphenyl-4-yl)-2-methyl-2-morpholinopropan-1-one via chlorination offers high yield and cost reduction for photoinitiator manufacturing.
Patent CN103242261A details a high-yield two-step synthesis for alpha-amino aromatic ketones, offering cost reduction and scalable production for UV curing industries.